Blackstone Inc’s Health Catalyst HCAT Stock Holding History

Blackstone Inc’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-77,900	Closed	-$2.7M	–	86
2019 Q4	$2.7M	Hold	77,900	–	–	0.02%	51
2019 Q3	$2.46M	Buy	+77,900	New	+$3.07M	0.01%	53

Other funds holding HCAT

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

NVPX

Norwest Venture Partners XI Palo Alto, California $32.1M AUM 15.68% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Blackstone Inc's HCAT Position: Q1 2020 in Review

Blackstone Inc sold out of Health Catalyst (HCAT) in Q1 2020, closing a stake of 77,900 shares — an estimated $2.7M sold.

Blackstone Inc first reported a position in HCAT in Q3 2019 and held it in 2 quarters. The position peaked at $2.7M in Q4 2019. 108 funds tracked by Wall St. Rank hold HCAT as of Q1 2020.

Blackstone Inc reported no remaining Health Catalyst position as of Q1 2020 after selling out during the quarter.
Blackstone Inc sold 77,900 Health Catalyst shares in Q1 2020, an estimated $2.7M.
Blackstone Inc first reported a position in Health Catalyst in Q3 2019 and held it in 2 quarters.
Blackstone Inc's Health Catalyst position peaked at $2.7M in Q4 2019.
108 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2020.

Based on Blackstone Inc's 13F filing for Q1 2020, filed 15 May 2020.